BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• 

  Funding

  Bain Raises $3B for Fourth Fund to Back Promising Life Sciences Companies

  Tuesday’s round brings Bain Capital Life Sciences’ fundraising total to around $6.7 billion since its founding in 2016. Many of its portfolio companies have resulted in high-value exits recently, including Cerevel Therapeutics, Aiolos Bio and Jnana Therapeutics.

  September 11, 2024

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Weight Loss

  Novo’s Obesity Pill Yields ‘Remarkable’ 13% Weight Loss, Investigators Say

  On the heels of Terns’ positive Phase I results that analysts compared with Lilly’s and Pfizer’s weight loss pills in development, Novo Nordisk showcased more details about its own oral candidate.

  September 11, 2024

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  Pendopharm announces public drug coverage plan listings for Octasa® (oral mesalamine)

  September 11, 2024

   · 

  3 min read
• Press Releases

  ‘Highly Accurate’: Telix’s Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology

  September 11, 2024

   · 

  9 min read
• Press Releases

  Oxford-Harrington Rare Disease Centre Appoints Influential UK Leader in Health Innovation Policy, Baroness Nicola Blackwood, to its Advisory Council

  September 11, 2024

   · 

  5 min read
• Press Releases

  SOLASTA Bio Completes $14m Series A to Accelerate Nature-Inspired Crop Protection

  September 11, 2024

   · 

  11 min read
• Press Releases

  MTTI at the 2nd Annual Targeted Radionuclide Pharmaceuticals Supply Chain & Manufacturing Summit

  September 11, 2024

   · 

  2 min read
• Press Releases

  Zomedica Completes Renovation & Upgrade of Manufacturing, Distribution, and R&D Center in Plymouth, Minnesota

  September 11, 2024

   · 

  7 min read
• Press Releases

  Arch Biopartners Announces Alberta Health Services Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)

  September 11, 2024

   · 

  5 min read
• Press Releases

  Xencor Announces Pricing of $175 Million Public Offering of Common Stock

  September 11, 2024

   · 

  4 min read